Literature DB >> 9704769

Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis.

G P Sacks1, K Studena, K Sargent, C W Redman.   

Abstract

OBJECTIVE: Our aim was to seek evidence for circulating leukocyte activation in preeclampsia. STUDY
DESIGN: Whole blood flow cytometric techniques were used to analyze surface markers of activation (CD11b, CD14, CD23, CD49d, CD62L, CD64, CD66b, HLA-DR) and intracellular reactive oxygen species. Samples were taken from 21 women with preeclampsia, 21 matched normal pregnant women, 21 healthy nonpregnant controls, and 6 nonpregnant patients with septicemia. Ten preeclamptic cases were followed up 6 weeks post partum.
RESULTS: The leukocytes of healthy pregnant women differed substantially and significantly from those of nonpregnant women (increased CD11b, CD14, and CD64 and increased intracellular reactive oxygen species). In preeclampsia there was, in addition to these changes, reduced expression of L-selectin and further increases in intracellular reactive oxygen species. The changes found in normal pregnancy and preeclampsia were similar, but not identical, to those found in sepsis.
CONCLUSIONS: Normal third-trimester pregnancy is characterized by remarkable activation of peripheral blood leukocytes, which is further increased in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704769     DOI: 10.1016/s0002-9378(98)70254-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  224 in total

1.  Spontaneous labour at term is associated with fetal monocyte activation.

Authors:  A Steinborn; C Sohn; C Sayehli; A Baudendistel; D Hüwelmeier; C Solbach; E Schmitt; M Kaufmann
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 2.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

3.  Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells.

Authors:  G P Sacks; C W G Redman; I L Sargent
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

4.  Neutrophil release of myeloperoxidase in systemic vasculature of obese women may put them at risk for preeclampsia.

Authors:  Juhi Shukla; Scott W Walsh
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

5.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Piya Chaemsaithong; Zhonghui Xu; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Done; Sonia S Hassan; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2017-03-03       Impact factor: 8.661

Review 6.  Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening?

Authors:  Naveed Sattar; Ian A Greer
Journal:  BMJ       Date:  2002-07-20

7.  Interleukin-33 in the human placenta.

Authors:  Vanessa Topping; Roberto Romero; Nandor Gabor Than; Adi L Tarca; Zhonghui Xu; Sun Young Kim; Bing Wang; Lami Yeo; Chong Jai Kim; Sonia S Hassan; Jung-Sun Kim
Journal:  J Matern Fetal Neonatal Med       Date:  2012-11-23

8.  The two stage model of preeclampsia: variations on the theme.

Authors:  J M Roberts; C A Hubel
Journal:  Placenta       Date:  2008-12-13       Impact factor: 3.481

Review 9.  Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies.

Authors:  Luis O Rustveld; Sheryl F Kelsey; Ravi Sharma
Journal:  Matern Child Health J       Date:  2007-06-19

Review 10.  The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences.

Authors:  Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.